{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:52:38Z","timestamp":1761807158538},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.neulet.2005.03.019","type":"journal-article","created":{"date-parts":[[2005,4,9]],"date-time":"2005-04-09T07:57:04Z","timestamp":1113033424000},"page":"231-235","source":"Crossref","is-referenced-by-count":23,"title":["Effect of the cannabinoid ajulemic acid on rat models of neuropathic and inflammatory pain"],"prefix":"10.1016","volume":"382","author":[{"given":"Vanessa A.","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevda","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Safaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher W.","family":"Vaughan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2005.03.019_bib1","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neulet.2005.03.019_bib2","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/sj.bjp.0704110","article-title":"The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain","volume":"133","author":"Bridges","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neulet.2005.03.019_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0163-7258(98)00069-2","article-title":"The cannabinoid acids: nonpsychoactive derivatives with therapeutic potential","volume":"82","author":"Burstein","year":"1999","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neulet.2005.03.019_bib4","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1021\/jm00095a007","article-title":"Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic, and leukocyte antiadhesion activities","volume":"35","author":"Burstein","year":"1992","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neulet.2005.03.019_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0024-3205(98)00256-2","article-title":"Analgesic effects of 1\u2032,1\u2032-dimethylheptyl-delta(8)-THC-11-oic acid (CT3) in mice","volume":"63","author":"Burstein","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.neulet.2005.03.019_bib6","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.lfs.2004.04.010","article-title":"Ajulemic acid: a novel cannabinoid produces analgesia without a \u201chigh\u201d","volume":"75","author":"Burstein","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.neulet.2005.03.019_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative asessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neulet.2005.03.019_bib8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0304-3959(01)00454-7","article-title":"CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain","volume":"96","author":"Clayton","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.neulet.2005.03.019_bib9","first-page":"218","article-title":"Cannabinoid structure\u2013activity relationships: correlation of receptor binding and in vivo activities","volume":"265","author":"Compton","year":"1993","journal-title":"J. Pharmacol. Exp Ther."},{"key":"10.1016\/j.neulet.2005.03.019_bib10","first-page":"31","article-title":"1\u2032,1\u2032-Dimethylheptyl-delta-8-tetrahydrocannabinol-11-oic acid: a novel, orally effective cannabinoid with analgesic and anti-inflammatory properties","volume":"291","author":"Dajani","year":"1999","journal-title":"J. Pharmacol. Exp Ther."},{"key":"10.1016\/j.neulet.2005.03.019_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3959(00)00474-7","article-title":"The role of central and peripheral cannabinoid(1) receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain","volume":"92","author":"Fox","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.neulet.2005.03.019_bib12","doi-asserted-by":"crossref","first-page":"14228","DOI":"10.1073\/pnas.96.25.14228","article-title":"HU-308: A specific agonist for CB2, a peripheral cannabinoid receptor","volume":"96","author":"Hanus","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neulet.2005.03.019_bib13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3940(96)13308-5","article-title":"The analgesic effects of R(+)-WIN 55, 212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain","volume":"221","author":"Herzberg","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2005.03.019_bib14","doi-asserted-by":"crossref","first-page":"10529","DOI":"10.1073\/pnas.1834309100","article-title":"Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS","volume":"100","author":"Ibrahim","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neulet.2005.03.019_bib15","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1001\/jama.290.13.1757","article-title":"Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain\u2014a randomized controlled trial","volume":"290","author":"Karst","year":"2003","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.neulet.2005.03.019_bib16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0304-3959(02)00450-5","article-title":"A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain","volume":"103","author":"Kehl","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.neulet.2005.03.019_bib17","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1124\/mol.63.5.983","article-title":"Activation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acid","volume":"63","author":"Liu","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neulet.2005.03.019_bib18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0304-3959(01)00321-9","article-title":"CB2 cannabinoid receptor-mediated peripheral antinociception","volume":"93","author":"Malan","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.neulet.2005.03.019_bib19","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0301-0082(00)00031-9","article-title":"Cannabinoid receptors and pain","volume":"63","author":"Pertwee","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neulet.2005.03.019_bib20","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0006-2952(01)00700-6","article-title":"Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid","volume":"62","author":"Recht","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neulet.2005.03.019_bib21","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1021\/jm970126f","article-title":"Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase","volume":"40","author":"Rhee","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neulet.2005.03.019_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0304-3959(90)91074-S","article-title":"A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury","volume":"43","author":"Seltzer","year":"1990","journal-title":"Pain"},{"key":"10.1016\/j.neulet.2005.03.019_bib23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0091-3057(97)00583-2","article-title":"Characterization of \u03949-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats","volume":"60","author":"Smith","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neulet.2005.03.019_bib24","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/art.20050","article-title":"A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritis","volume":"50","author":"Sumariwalla","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.neulet.2005.03.019_bib25","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0006-2952(02)01604-0","article-title":"Suppression of human monocyte interleukin-1 beta production by ajulemic acid, a nonpsychoactive cannabinoid","volume":"65","author":"Zurier","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neulet.2005.03.019_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/1529-0131(199801)41:1<163::AID-ART20>3.0.CO;2-9","article-title":"Dimethylheptyl-THC-11 oic acid: a nonpsychoactive antiinflammatory agent with a cannabinoid template structure","volume":"41","author":"Zurier","year":"1998","journal-title":"Arthritis Rheum."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394005003137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394005003137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T09:57:30Z","timestamp":1548583050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394005003137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0304394005003137"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2005.03.019","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}